S&P 500 Futures
(0.19%) 5 141.00 points
Dow Jones Futures
(0.19%) 38 513 points
Nasdaq Futures
(0.25%) 17 891 points
Oil
(-0.93%) $83.07
Gas
(1.56%) $1.953
Gold
(-0.34%) $2 339.20
Silver
(-0.31%) $27.45
Platinum
(0.26%) $924.50
USD/EUR
(-0.13%) $0.934
USD/NOK
(-0.06%) $11.02
USD/GBP
(-0.20%) $0.799
USD/RUB
(0.86%) $92.67

Sanntidsoppdatering for Sihuan Pharmaceutical [0460.HK]

Børs: HKSE Industri: Drug Manufacturers
Sist oppdatert29 apr 2024 @ 08:46

0.00% HKD 0.560

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 08:46):

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China...

Stats
Dagens volum 13.57M
Gjennomsnittsvolum 7.60M
Markedsverdi 5.20B
EPS HKD0 ( 2024-03-27 )
Last Dividend HKD0.0370 ( 2023-06-06 )
Next Dividend HKD0 ( N/A )
P/E -56.00
ATR14 HKD0.00100 (0.18%)

Volum Korrelasjon

Lang: 0.04 (neutral)
Kort: 0.00 (neutral)
Signal:(50.538) Neutral

Sihuan Pharmaceutical Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Sihuan Pharmaceutical Korrelasjon - Valuta/Råvare

The country flag 0.30
( neutral )
The country flag 0.58
( weak )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.31
( neutral )

Sihuan Pharmaceutical Økonomi

Annual 2023
Omsetning: HKD1.86B
Bruttogevinst: HKD1.30B (69.64 %)
EPS: HKD-0.00580
FY 2023
Omsetning: HKD1.86B
Bruttogevinst: HKD1.30B (69.64 %)
EPS: HKD-0.00580
FY 2022
Omsetning: HKD2.18B
Bruttogevinst: HKD1.49B (68.20 %)
EPS: HKD-0.210
FY 2021
Omsetning: HKD3.29B
Bruttogevinst: HKD2.45B (74.39 %)
EPS: HKD0.0440

Financial Reports:

No articles found.

Sihuan Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0360
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.0370
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Sihuan Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.27 - low (8.85%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.0390 2011-09-21
Last Dividend HKD0.0370 2023-06-06
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 23 --
Total Paid Out HKD0.764 --
Avg. Dividend % Per Year 0.00% --
Score 1.03 --
Div. Sustainability Score 3.27
Div.Growth Potential Score 0
Div. Directional Score 0.991 --
Next Divdend (Est)
(2024-10-25)
HKD0.0364 Estimate 3.62 %
Dividend Stability
0.29 Very Poor
Dividend Score
1.03
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
87001.HK Ex Dividend Junior 2023-08-10 Semi-Annually 0 0.00%
2107.HK Ex Dividend Junior 2023-06-29 Annually 0 0.00%
1114.HK Ex Dividend Junior 2023-08-11 Annually 0 0.00%
0189.HK Ex Dividend Junior 2023-06-14 Annually 0 0.00%
3808.HK Ex Dividend Junior 2023-07-04 Annually 0 0.00%
1696.HK Ex Dividend Junior 2023-08-24 Annually 0 0.00%
0730.HK Ex Dividend Junior 2023-05-24 Annually 0 0.00%
2283.HK Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
1270.HK Ex Dividend Knight 2023-05-16 Annually 0 0.00%
0323.HK No Dividend Player 2023-06-21 Sporadic 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.02901.500-0.581-0.871[0 - 0.5]
returnOnAssetsTTM-0.004681.200-0.156-0.187[0 - 0.3]
returnOnEquityTTM-0.01221.500-1.247-1.870[0.1 - 1]
payoutRatioTTM-5.53-1.000-10.0010.00[0 - 1]
currentRatioTTM1.5110.8007.455.96[1 - 3]
quickRatioTTM1.1600.8007.886.30[0.8 - 2.5]
cashRatioTTM0.9201.5006.009.00[0.2 - 2]
debtRatioTTM0.106-1.5008.23-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.003182.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM-0.005102.00-0.00255-0.00510[0 - 20]
debtEquityRatioTTM0.277-1.5008.89-10.00[0 - 2.5]
grossProfitMarginTTM0.6961.0001.7271.727[0.2 - 0.8]
operatingProfitMarginTTM-0.07361.000-3.47-3.47[0.1 - 0.6]
cashFlowToDebtRatioTTM0.02311.000-0.983-0.983[0.2 - 2]
assetTurnoverTTM0.1610.800-2.26-1.806[0.5 - 2]
Total Score3.27

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-85.441.000-8.730[1 - 100]
returnOnEquityTTM-0.01222.50-0.802-1.870[0.1 - 1.5]
freeCashFlowPerShareTTM-0.005102.00-0.00170-0.00510[0 - 30]
dividendYielPercentageTTM7.141.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.003182.0010.0010.00[0 - 30]
payoutRatioTTM-5.531.500-10.0010.00[0 - 1]
pegRatioTTM-0.9341.500-9.560[0.5 - 2]
operatingCashFlowSalesRatioTTM0.01521.000-2.120[0.1 - 0.5]
Total Score-1.286

Sihuan Pharmaceutical

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.